http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013540157-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-1136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-14
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2011-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013540157-A
titleOfInvention Method for treating inclusion bodies
abstract The present invention relates to methods for purifying recombinant proteins such as antibodies and antibody fragments. Preferably, the method uses depth filtration to clarify the desired protein from the solubilized mixture, and also allows the recombinant protein to be regenerated into a functional and active protein. A reproduction method and a reproduction buffer are provided. Examples of antibody fragments include anti-CD22 antibody fragments comprising VH and VL chains that are regenerated into functional and active fragments. [Selection] Figure 6
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018529654-A
priorityDate 2010-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008125580-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006511463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03102013-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009015736-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009130103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009132244-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65359
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587403
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554224
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02879
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5PY51
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537902

Total number of triples: 44.